{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:12:32Z","timestamp":1780395152345,"version":"3.54.1"},"reference-count":204,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Discovery Grant of the Natural Sciences and Engineering Research Council (NSERC) of Canada","award":["RGPIN2016 05369"],"award-info":[{"award-number":["RGPIN2016 05369"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD), the most common liver disease worldwide, is a spectrum of liver abnormalities ranging from steatosis to nonalcoholic steatohepatitis (NASH) characterized by excessive lipid accumulation. The prevalence of NAFLD is predicted to increase rapidly, demanding novel approaches to reduce the global NAFLD burden. Flavonoids, the most abundant dietary polyphenols, can reduce the risk of NAFLD. The majority of dietary flavonoids are proanthocyanidins (PACs), which are oligomers and polymers of the flavonoid sub-group flavan-3-ols. The efficacy of PAC in reducing the NAFLD risk can be significantly hindered by low bioavailability. The development of synbiotics by combining PAC with probiotics may increase effectiveness against NAFLD by biotransforming PAC into bioavailable metabolites. PAC and probiotic bacteria are capable of mitigating steatosis primarily through suppressing de novo lipogenesis and promoting fatty acid \u03b2-oxidation. PAC and probiotic bacteria can reduce the progression of steatosis to NASH mainly through ameliorating hepatic damage and inflammation induced by hepatic oxidative stress, endoplasmic reticulum stress, and gut microbiota dysbiosis. Synbiotics of PAC are superior in reducing the risk of NAFLD compared to independent administration of PAC and probiotics. The development of PAC-based synbiotics can be a novel strategy to mitigate the increasing incidence of NAFLD.<\/jats:p>","DOI":"10.3390\/molecules29030709","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T05:36:43Z","timestamp":1707197803000},"page":"709","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2835-8819","authenticated-orcid":false,"given":"Wasitha P. D. W.","family":"Thilakarathna","sequence":"first","affiliation":[{"name":"Department of Plant, Food, and Environmental Sciences, Faculty of Agriculture, Dalhousie University, Truro, NS B2N 5E3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-0052","authenticated-orcid":false,"given":"H. P. Vasantha","family":"Rupasinghe","sequence":"additional","affiliation":[{"name":"Department of Plant, Food, and Environmental Sciences, Faculty of Agriculture, Dalhousie University, Truro, NS B2N 5E3, Canada"},{"name":"Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jceh.2019.07.008","article-title":"Extra-hepatic manifestations of nonalcoholic fatty liver disease: A review","volume":"10","author":"Tariq","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int."},{"key":"ref_5","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fernando, D.H., Forbes, J.M., Angus, P.W., and Herath, C.B. (2019). Development and progression of non-alcoholic fatty liver disease: The role of advanced glycation end products. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205037"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/tgh.2020.02.21","article-title":"Fibrosis and hepatic regeneration mechanism","volume":"7","year":"2022","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Suresh, D., Srinivas, A.N., and Kumar, D.P. (2020). Etiology of Hepatocellular carcinoma: Special focus on fatty liver disease. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.601710"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic fatty liver disease in adults: Current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kosmalski, M., Zi\u00f3\u0142kowska, S., Czarny, P., Szemraj, J., and Pietras, T. (2022). The coexistence of nonalcoholic fatty liver disease and type 2 diabetes mellitus. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051375"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2050312117745223","DOI":"10.1177\/2050312117745223","article-title":"Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"6","author":"Rezayat","year":"2018","journal-title":"SAGE Open Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: Heterogeneous associations with metabolic changes","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"572490","DOI":"10.3389\/fendo.2020.572490","article-title":"Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: Relevance of estrogen signaling","volume":"11","author":"Torre","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Riazi, K., Swain, M.G., Congly, S.E., Kaplan, G.G., and Shaheen, A.-A. (2022). Race and ethnicity in non-alcoholic fatty liver disease (NAFLD): A narrative review. Nutrients, 14.","DOI":"10.3390\/nu14214556"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jceh.2020.09.001","article-title":"What are the current pharmacological therapies for nonalcoholic fatty liver disease?","volume":"11","author":"David","year":"2021","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","first-page":"371","article-title":"Update on clinical trials for nonalcoholic steatohepatitis","volume":"19","author":"Nathani","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Abenavoli, L., Larussa, T., Corea, A., Procopio, A.C., Boccuto, L., Dallio, M., Federico, A., and Luzza, F. (2021). Dietary polyphenols and non-alcoholic fatty liver disease. Nutrients, 13.","DOI":"10.3390\/nu13020494"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.foodchem.2014.07.103","article-title":"Antioxidant and cytoprotective properties of partridgeberry polyphenols","volume":"168","author":"Bhullar","year":"2015","journal-title":"Food Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biori.2019.03.001","article-title":"Differential distribution of polyphenols in plants using multivariate techniques","volume":"3","author":"Kumar","year":"2019","journal-title":"Biotechnol. Res. Innov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2251-6581-12-43","article-title":"Dietary polyphenols as potential nutraceuticals in management of diabetes: A review","volume":"12","author":"Bahadoran","year":"2013","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Rupasinghe, H.P.V. (2020). Special issue \u201cflavonoids and their disease prevention and treatment potential\u201d: Recent advances and future perspectives. Molecules, 25.","DOI":"10.3390\/molecules25204746"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/biof.1249","article-title":"Proanthocyanidins in health and disease","volume":"42","author":"Muguerza","year":"2016","journal-title":"BioFactors"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mannino, G., Chinig\u00f2, G., Serio, G., Genova, T., Gentile, C., Munaron, L., and Bertea, C.M. (2021). Proanthocyanidins and where to find them: A meta-analytic approach to investigate their chemistry, biosynthesis, distribution, and effect on human health. Antioxidants, 10.","DOI":"10.3390\/antiox10081229"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/1750-3841.14386","article-title":"Proanthocyanidins with a low degree of polymerization are good inhibitors of digestive enzymes because of their ability to form specific interactions: A hypothesis","volume":"83","author":"Aguilar","year":"2018","journal-title":"J. Food Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/bph.13630","article-title":"Proanthocyanidins and hydrolysable tannins: Occurrence, dietary intake and pharmacological effects","volume":"174","author":"Smeriglio","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/advances\/nmy118","article-title":"Proanthocyanidins of natural origin: Molecular mechanisms and implications for lipid disorder and aging-associated diseases","volume":"10","author":"Nie","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mnfr.200900194","article-title":"Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy","volume":"54","author":"Stalmach","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mnfr.201400243","article-title":"Microbial catabolism of procyanidins by human gut microbiota","volume":"58","author":"Ou","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Niwano, Y., Kohzaki, H., Shirato, M., Shishido, S., and Nakamura, K. (2022). Metabolic fate of orally ingested proanthocyanidins through the digestive tract. Antioxidants, 12.","DOI":"10.3390\/antiox12010017"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.toxlet.2023.03.005","article-title":"Hepatotoxicity of polymeric proanthocyanidins is caused by translocation of bacterial lipopolysaccharides through impaired gut epithelium","volume":"379","author":"Thilakarathna","year":"2023","journal-title":"Toxicol. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.fct.2019.02.010","article-title":"Microbial metabolites of proanthocyanidins reduce chemical carcinogen-induced dna damage in human lung epithelial and fetal hepatic cells in vitro","volume":"125","author":"Thilakarathna","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_36","first-page":"730","article-title":"Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes","volume":"1861","author":"Hung","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s00125-016-4037-x","article-title":"Effects of exercise training on intrahepatic lipid content in humans","volume":"59","author":"Brouwers","year":"2016","journal-title":"Diabetologia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Li, H., Herrmann, T., See\u00dfle, J., Liebisch, G., Merle, U., Stremmel, W., and Chamulitrat, W. (2022). Role of fatty acid transport protein 4 in metabolic tissues: Insights into obesity and fatty liver disease. Biosci. Rep., 42.","DOI":"10.1042\/BSR20211854"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11418-022-01647-w","article-title":"Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease","volume":"77","author":"Ran","year":"2023","journal-title":"J. Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Ochoa","year":"2011","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101428","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2021.0157","article-title":"Inhibition of fatty acid translocase (FAT\/CD36) palmitoylation enhances hepatic fatty acid \u03b2-oxidation by increasing its localization to mitochondria and interaction with long-chain acyl-coa synthetase 1","volume":"36","author":"Zeng","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","article-title":"Apoptosis is associated with CD36\/Fatty acid translocase upregulation in non-alcoholic steatohepatitis","volume":"30","author":"Bechmann","year":"2010","journal-title":"Liver Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e20211314","DOI":"10.1084\/jem.20211314","article-title":"CD36, a Signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1021\/bi051999b","article-title":"Role of caveolin-1 and cholesterol in transmembrane fatty acid movement","volume":"45","author":"Meshulam","year":"2006","journal-title":"Biochemistry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1499-3872(13)60099-5","article-title":"Upregulation of caveolin-1 and sr-b1 in mice with non-alcoholic fatty liver disease","volume":"12","author":"Qiu","year":"2013","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbalip.2006.03.016","article-title":"Caveolin-1 is required for fatty acid translocase (FAT\/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts","volume":"1761","author":"Ring","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/cas.13659","article-title":"Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease","volume":"109","author":"Takeda","year":"2018","journal-title":"Cancer Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"172910","DOI":"10.1016\/j.ejphar.2020.172910","article-title":"Caveolin-1 alleviates lipid accumulation in nafld associated with promoting autophagy by inhibiting the Akt\/mTOR pathway","volume":"871","author":"Xue","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pharmthera.2016.06.005","article-title":"Phytochemicals in regulating fatty acid \u03b2-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss","volume":"165","author":"Rupasinghe","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Savic, D., Hodson, L., Neubauer, S., and Pavlides, M. (2020). The importance of the fatty acid transporter l-carnitine in non-alcoholic fatty liver disease (NAFLD). Nutrients, 12.","DOI":"10.3390\/nu12082178"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/liv.14309","article-title":"Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study","volume":"40","author":"Naguib","year":"2020","journal-title":"Liver Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1758-5996-3-31","article-title":"L-carnitine ameliorated fatty liver in high-calorie diet\/STZ-induced type 2 diabetic mice by improving mitochondrial function","volume":"3","author":"Xia","year":"2011","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/osp4.460","article-title":"\u03b1-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease","volume":"7","author":"Tokoro","year":"2020","journal-title":"Obes. Sci. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gomaraschi, M., Fracanzani, A.L., Dongiovanni, P., Pavanello, C., Giorgio, E., Da Dalt, L., Norata, G.D., Calabresi, L., Consonni, D., and Lombardi, R. (2019). Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in nafld patients and cell cultures. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids, 1864.","DOI":"10.1016\/j.bbalip.2019.158523"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00041433-200104000-00008","article-title":"Very-low-density lipoprotein assembly and secretion","volume":"12","author":"Shelness","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M300508-JLR200","article-title":"Fatty liver in familial hypobetalipoproteinemia: Roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity","volume":"45","author":"Tanoli","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","article-title":"The role of the microsomal triglygeride transfer protein in abetalipoproteinemia","volume":"20","author":"Aggerbeck","year":"2000","journal-title":"Annu. Rev. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1210\/jc.2019-00875","article-title":"Hepatic fatty acid balance and hepatic fat content in humans with severe obesity","volume":"104","author":"Lytle","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.livres.2018.02.002","article-title":"The role of adipose tissue in fatty liver diseases","volume":"2","author":"Richard","year":"2018","journal-title":"Liver Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s43055-022-00949-z","article-title":"Visceral and subcutaneous fat, muscle mass, and liver volume as noninvasive predictors of the progress of non-alcoholic fatty liver disease","volume":"54","author":"Mahmoud","year":"2023","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.numecd.2022.01.009","article-title":"Visceral adipose tissue quality was associated with nonalcoholic fatty liver disease, independent of its quantity","volume":"32","author":"Igarashi","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Suchacki, K.J., and Stimson, R.H. (2021). Nutritional regulation of human brown adipose tissue. Nutrients, 13.","DOI":"10.3390\/nu13061748"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1038\/ncomms14146","article-title":"Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men","volume":"8","author":"Blondin","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1475-2840-11-100","article-title":"GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome","volume":"11","author":"Leguisamo","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jhep.2023.01.014","article-title":"Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue","volume":"78","author":"Falkevall","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A role of peroxisome proliferator-activated receptor \u03b3 in non-alcoholic fatty liver disease","volume":"124","author":"Lykkesfeldt","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.biopha.2018.11.120","article-title":"Hydroxytyrosol supplementation ameliorates the metabolic disturbances in white adipose tissue from mice fed a high-fat diet through recovery of transcription factors Nrf2, SREBP-1c, PPAR-\u03b3 and NF-\u03baB","volume":"109","author":"Illesca","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-\u03b3 mRNA expression in the liver of obese patients: An additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Titos","year":"2011","journal-title":"FASEB J."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Giorgio, V., Prono, F., Graziano, F., and Nobili, V. (2013). Pediatric non alcoholic fatty liver disease: Old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr., 13.","DOI":"10.1186\/1471-2431-13-40"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: Revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Rennert, C., Heil, T., Schicht, G., Stilkerich, A., Seidemann, L., Kegel-H\u00fcbner, V., Seehofer, D., and Damm, G. (2020). Prolonged lipid accumulation in cultured primary human hepatocytes rather leads to ER stress than oxidative stress. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197097"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yexcr.2017.08.006","article-title":"Disruption of the mitochondria-associated ER membrane (MAM) plays a central role in palmitic acid\u2013induced insulin resistance","volume":"359","author":"Shinjo","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"107401","DOI":"10.1016\/j.pharmthera.2019.107401","article-title":"The unfolded protein response and hepatic lipid metabolism in non-alcoholic fatty liver disease","volume":"203","author":"Song","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Cai, J., Zhang, X., Chen, P., Li, Y., Liu, S., Liu, Q., Zhang, H., Wu, Z., Song, K., and Liu, J. (2022). The ER stress sensor inositol-requiring enzyme 1\u03b1 in kupffer cells promotes hepatic ischemia-reperfusion injury. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2021.101532"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.celrep.2017.05.020","article-title":"ER stress inhibits liver fatty acid oxidation while unmitigated stress leads to anorexia-induced lipolysis and both liver and kidney steatosis","volume":"19","author":"Sheldon","year":"2017","journal-title":"Cell Rep."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, S.H., Kwon, D., Kwak, J.-H., Lee, S., Lee, Y.-H., Yun, J., Son, T.G., and Jung, Y.-S. (2018). Tunicamycin-induced er stress is accompanied with oxidative stress via abrogation of sulfur amino acids metabolism in the liver. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19124114"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Podszun, M.C., Alawad, A.S., Lingala, S., Morris, N., Huang, W.-C.A., Yang, S., Schoenfeld, M., Rolt, A., Ouwerkerk, R., and Valdez, K. (2020). Vitamin E treatment in nafld patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biol., 37.","DOI":"10.1016\/j.redox.2020.101710"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Michalak","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: A clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the role and interdependence of oxidative stress and inflammation in liver diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"111937","DOI":"10.1016\/j.fct.2020.111937","article-title":"Allicin alleviated acrylamide-induced NLRP3 inflammasome activation via oxidative stress and endoplasmic reticulum stress in Kupffer cells and SD rats liver","volume":"148","author":"Nan","year":"2021","journal-title":"Food Chem. Toxicol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/13813455.2018.1427764","article-title":"High glucose induces inflammatory responses in HepG2 cells via the oxidative stress-mediated activation of NF-\u03baB, and MAPK pathways in HepG2 cells","volume":"124","author":"Panahi","year":"2018","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"113141","DOI":"10.1016\/j.ecoenv.2021.113141","article-title":"TNF-\u03b1\/TNFR1 regulates the polarization of Kupffer cells to mediate trichloroethylene-induced liver injury","volume":"230","author":"Zhang","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5625\/lar.2018.34.4.133","article-title":"The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"34","author":"Cha","year":"2018","journal-title":"Lab. Anim. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jconrel.2021.11.039","article-title":"Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH","volume":"341","author":"Maeda","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_103","first-page":"1","article-title":"Oxidative stress and hepatic stellate cells: A paradoxical relationship","volume":"7","author":"Gandhi","year":"2012","journal-title":"Trends Cell Mol. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1074\/jbc.M109.074252","article-title":"Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis","volume":"285","author":"Alkhouri","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Reyes-Farias, M., Fos-Domenech, J., Serra, D., Herrero, L., and S\u00e1nchez-Infantes, D. (2021). White adipose tissue dysfunction in obesity and aging. Biochem. Pharmacol., 192.","DOI":"10.1016\/j.bcp.2021.114723"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","article-title":"Associations among adipose tissue immunology, inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease","volume":"161","author":"Fuchs","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","article-title":"Association of adipokines with development and progression of nonalcoholic fatty liver disease","volume":"33","author":"Boutari","year":"2018","journal-title":"Endocrinol. Metab."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","article-title":"Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"60","author":"Polyzos","year":"2011","journal-title":"Metabolism"},{"key":"ref_109","first-page":"127","article-title":"The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease","volume":"13","author":"Polyzos","year":"2009","journal-title":"Hippokratia"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3350\/cmh.2018.0011","article-title":"The association of leptin with severity of non-alcoholic fatty liver disease: A population-based study","volume":"24","author":"Rotundo","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ajpath.2021.11.008","article-title":"Leptin enhances hepatic fibrosis and inflammation in a mouse model of cholestasis","volume":"192","author":"Petrescu","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Thilakarathna, W.P.D.W., Rupasinghe, H.P.V., and Ridgway, N.D. (2021). Mechanisms by which probiotic bacteria attenuate the risk of hepatocellular carcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052606"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11894-022-00859-0","article-title":"Gut microbiome and its impact on obesity and obesity-related disorders","volume":"25","author":"Sankararaman","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3350\/cmh.2020.0125","article-title":"Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis","volume":"27","author":"Lee","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Yoon, S.J., Yu, J.S., Min, B.H., Gupta, H., Won, S.-M., Park, H.J., Han, S.H., Kim, B.-Y., Kim, K.H., and Kim, B.K. (2023). Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1129904"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nutres.2021.04.008","article-title":"A rise in proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice","volume":"91","author":"Miranda","year":"2021","journal-title":"Nutr. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41467-023-35861-1","article-title":"Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"32002","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/liv.12456","article-title":"Protective effects of farnesoid X receptor (FXR) on Hepatic Lipid Accumulation Are Mediated by Hepatic FXR and independent of intestinal FGF15 signal","volume":"35","author":"Schmitt","year":"2015","journal-title":"Liver Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor \u03b1 gene via activation of the farnesoid X receptor","volume":"17","author":"Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against nafld via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"111650","DOI":"10.1016\/j.mce.2022.111650","article-title":"Immunomodulatory functions of FXR","volume":"551","author":"Fiorucci","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fphys.2016.00646","article-title":"TGR5, not only a metabolic regulator","volume":"7","author":"Guo","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Xie, G., Jiang, R., Wang, X., Liu, P., Zhao, A., Wu, Y., Huang, F., Liu, Z., Rajani, C., and Zheng, X. (2021). Conjugated secondary 12\u03b1-hydroxylated bile acids promote liver fibrogenesis. EBioMedicine, 66.","DOI":"10.1016\/j.ebiom.2021.103290"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Aoki, R., Onuki, M., Hattori, K., Ito, M., Yamada, T., Kamikado, K., Kim, Y.-G., Nakamoto, N., Kimura, I., and Clarke, J.M. (2021). Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice. Microbiome, 9.","DOI":"10.1186\/s40168-021-01125-7"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3892\/etm.2022.11536","article-title":"A Potential link between plasma short-chain fatty acids, TNF-\u03b1 level and disease progression in non-alcoholic fatty liver disease: A retrospective study","volume":"24","author":"Xiong","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human nafld as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"769501","DOI":"10.3389\/fphar.2021.769501","article-title":"New insights into gut-bacteria-derived indole and its derivatives in intestinal and liver diseases","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1096\/fj.201800544","article-title":"The gut microbiota metabolite indole alleviates liver inflammation in mice","volume":"32","author":"Beaumont","year":"2018","journal-title":"FASEB J."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ji, Y., Gao, Y., Chen, H., Yin, Y., and Zhang, W. (2019). Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress. Nutrients, 11.","DOI":"10.3390\/nu11092062"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Chen, J., and Vitetta, L. (2020). Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155214"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and nash","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/jgh.15027","article-title":"Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"35","author":"Chen","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Park, J.-W., Kim, S.-E., Lee, N.Y., Kim, J.-H., Jung, J.-H., Jang, M.-K., Park, S.-H., Lee, M.-S., Kim, D.-J., and Kim, H.-S. (2022). Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010426"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Fei, N., Bruneau, A., Zhang, X., Wang, R., Wang, J., Rabot, S., G\u00e9rard, P., and Zhao, L. (2020). Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease. mBio, 11.","DOI":"10.1128\/mBio.03263-19"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"ref_143","first-page":"1824","article-title":"Resveratrol inhibits LPS-induced inflammation through suppressing the signaling cascades of TLR4-NF-\u03baB\/MAPKs\/IRF3","volume":"19","author":"Tong","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jss.2012.11.051","article-title":"Role of Kupffer cells and toll-like receptor 4 in acetaminophen-induced acute liver failure","volume":"180","author":"Fisher","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0023677215570087","article-title":"Lipopolysaccharide-induced inflammatory liver injury in mice","volume":"49","author":"Hamesch","year":"2015","journal-title":"Lab Anim."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fmed.2020.00130","article-title":"Pro- and anti-fibrogenic functions of gram-negative bacterial lipopolysaccharide in the liver","volume":"7","author":"Gandhi","year":"2020","journal-title":"Front. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3164\/jcbn.13-49","article-title":"Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats","volume":"54","author":"Fukunishi","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30652","article-title":"Fructose promotes leaky gut, endotoxemia and liver fibrosis through CYP2E1-mediated oxidative and nitrative stress","volume":"73","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Milner, E., Stevens, B., An, M., Lam, V., Ainsworth, M., Dihle, P., Stearns, J., Dombrowski, A., Rego, D., and Segars, K. (2021). Utilizing probiotics for the prevention and treatment of gastrointestinal diseases. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.689958"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zommiti, M., Feuilloley, M.G.J., and Connil, N. (2020). Update of probiotics in human world: A nonstop source of benefactions till the end of time. Microorganisms, 8.","DOI":"10.3390\/microorganisms8121907"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Gu, Y., Li, X., Chen, H., Sun, Y., Yang, L., Ma, Y., and Yong Chan, E.C. (2022). Antidiabetic effects of multi-species probiotic and its fermented milk in mice via restoring gut microbiota and intestinal barrier. Food Biosci., 47.","DOI":"10.1016\/j.fbio.2022.101619"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related nash by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e21464","DOI":"10.1097\/MD.0000000000021464","article-title":"Protective effect of probiotics in patients with non-alcoholic fatty liver disease","volume":"99","author":"Cai","year":"2020","journal-title":"Medicine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.fshw.2022.04.034","article-title":"Yogurt-derived Lactobacillus plantarum Q16 alleviated high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"11","author":"Tang","year":"2022","journal-title":"Food Sci. Hum. Wellness"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"121286","DOI":"10.1016\/j.lfs.2022.121286","article-title":"Amelioration of obesity-induced white adipose tissue inflammation by Bacillus coagulans T4 in a high-fat diet-induced obese murine model","volume":"314","author":"Hashemnia","year":"2023","journal-title":"Life Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"104078","DOI":"10.1016\/j.jff.2020.104078","article-title":"Intervention of five strains of lactobacillus on obesity in mice induced by high-fat diet","volume":"72","author":"Wang","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"104206","DOI":"10.1016\/j.jff.2020.104206","article-title":"Protective effects of lactobacillus acidophilus NX2-6 against oleic acid-induced steatosis, mitochondrial dysfunction, endoplasmic reticulum stress and inflammatory responses","volume":"74","author":"Tang","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"16206","DOI":"10.1038\/s41598-022-20296-3","article-title":"Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice","volume":"12","author":"Arai","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"106020","DOI":"10.1016\/j.phrs.2021.106020","article-title":"Lactobacillus acidophilus ameliorates obesity in mice through modulation of gut microbiota dysbiosis and intestinal permeability","volume":"175","author":"Kang","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2264737","DOI":"10.1155\/2021\/2264737","article-title":"Probiotics alleviated nonalcoholic fatty liver disease in high-fat diet-fed rats via gut microbiota\/FXR\/FGF15 signaling pathway","volume":"2021","author":"Luo","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.22980","article-title":"A specific role for dgat1 in hepatic steatosis due to exogenous fatty acids","volume":"50","author":"Villanueva","year":"2009","journal-title":"Hepatology"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Wang, X., Rao, H., Liu, F., Wei, L., Li, H., and Wu, C. (2021). Recent advances in adipose tissue dysfunction and its role in the pathogenesis of non-alcoholic fatty liver disease. Cells, 10.","DOI":"10.3390\/cells10123300"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41598-017-00671-1","article-title":"TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice","volume":"7","author":"Thiele","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.ajpath.2019.07.019","article-title":"Smooth muscle \u03b1-actin deficiency leads to decreased liver fibrosis via impaired cytoskeletal signaling in hepatic stellate cells","volume":"189","author":"Rockey","year":"2019","journal-title":"Am. J. Pathol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Jasirwan, C.O.M., Lesmana, C.R.A., Hasan, I., Sulaiman, A.S., and Gani, R.A. (2019). The role of gut microbiota in non-alcoholic fatty liver disease: Pathways of mechanisms. Biosci. Microbiota Food Health, 38.","DOI":"10.12938\/bmfh.18-032"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7150\/ijbs.56214","article-title":"Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: Recent updates","volume":"17","author":"Khan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.nut.2018.10.002","article-title":"Probiotics Improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet","volume":"60","author":"Kong","year":"2019","journal-title":"Nutrition"},{"key":"ref_171","first-page":"e132309","article-title":"Effectiveness of grape seed extract in patients with nonalcoholic fatty liver: A randomized double-blind clinical study","volume":"22","author":"Hemmati","year":"2022","journal-title":"Hepat. Mon."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"105297","DOI":"10.1016\/j.jff.2022.105297","article-title":"Chinese Bayberry (Myrica rubra sieb. et Zucc.) leaves proanthocyanidins alleviate insulin-resistance via activating PI3K\/AKT pathway in HepG2 cells","volume":"99","author":"Wang","year":"2022","journal-title":"J. Funct. Foods"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jff.2016.12.030","article-title":"Proanthocyanidins from chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves regulate lipid metabolism and glucose consumption by activating AMPK Pathway in HepG2 cells","volume":"29","author":"Zhang","year":"2017","journal-title":"J. Funct. Foods"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Feldman, F., Koudoufio, M., El-Jalbout, R., Sauv\u00e9, M.F., Ahmarani, L., San\u00e9, A.T., Ould-Chikh, N.-E.-H., N\u2019Timbane, T., Patey, N., and Desjardins, Y. (2023). Cranberry proanthocyanidins as a therapeutic strategy to curb metabolic syndrome and fatty liver-associated disorders. Antioxidants, 12.","DOI":"10.3390\/antiox12010090"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"959906","DOI":"10.3389\/fvets.2022.959906","article-title":"Dietary grape seed proanthocyanidin alleviates the liver injury induced by long-term high-fat diets in Sprague Dawley rats","volume":"9","author":"Sun","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/153897","article-title":"Grape seed proanthocyanidin rescues rats from steatosis: A comparative and combination study with metformin","volume":"2013","author":"Yogalakshmi","year":"2013","journal-title":"J. Lipids"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.freeradbiomed.2018.08.024","article-title":"Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state","volume":"126","author":"Su","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"786682","DOI":"10.3389\/fnut.2021.786682","article-title":"Grape seed proanthocyanidin alleviates intestinal inflammation through gut microbiota-bile acid crosstalk in mice","volume":"8","author":"Wu","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"104285","DOI":"10.1016\/j.jff.2020.104285","article-title":"Procyanidin B2 prevents dyslipidemia via modulation of gut microbiome and related metabolites in high-fat diet fed mice","volume":"75","author":"Xiao","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1039\/D1FO04147A","article-title":"Proanthocyanidins from chinese bayberry leaves reduce obesity and associated metabolic disorders in high-fat diet-induced obese mice through a combination of AMPK activation and an alteration in gut microbiota","volume":"13","author":"Zhang","year":"2022","journal-title":"Food Funct."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"91127","DOI":"10.1007\/s11356-022-22051-7","article-title":"Proanthocyanidins attenuated liver damage and suppressed fibrosis in CCl4-treated rats","volume":"29","author":"Amer","year":"2022","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.biopha.2017.06.105","article-title":"Oligomeric Proanthocyanidin derived from grape seeds inhibited NF-\u03baB signaling in activated HSC: Involvement of JNK\/ERK MAPK and PI3K\/Akt pathways","volume":"93","author":"Jiang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jn\/nxy088","article-title":"Daily consumption of synbiotic yogurt decreases liver steatosis in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial","volume":"148","author":"Bakhshimoghaddam","year":"2018","journal-title":"J. Nutr."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled pilot study1,2,3","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: A pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br. J. Nutr."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Ju\u00e1rez-Fern\u00e1ndez, M., Porras, D., Petrov, P., Rom\u00e1n-Sag\u00fcillo, S., Garc\u00eda-Mediavilla, M.V., Soluyanova, P., Mart\u00ednez-Fl\u00f3rez, S., Gonz\u00e1lez-Gallego, J., Nistal, E., and Jover, R. (2021). The synbiotic combination of Akkermansia muciniphila and quercetin ameliorates early obesity and NAFLD through gut microbiota reshaping and bile acid metabolism modulation. Antioxidants, 10.","DOI":"10.3390\/antiox10122001"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"105961","DOI":"10.1016\/j.jff.2023.105961","article-title":"Proanthocyanidins biotransformed by Saccharomyces cerevisiae prevent the pathogenesis of steatosis and progression to steatohepatitis in vitro","volume":"112","author":"Thilakarathna","year":"2024","journal-title":"J. Funct. Foods"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1021\/acs.jafc.8b03720","article-title":"Antiobesity effect of prebiotic polyphenol-rich grape seed flour supplemented with probiotic kefir-derived lactic acid bacteria","volume":"66","author":"Cho","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1801040","DOI":"10.1002\/mnfr.201801040","article-title":"Combination of whole grapeseed flour and newly isolated kefir lactic acid bacteria reduces high-fat-induced hepatic steatosis","volume":"63","author":"Kwon","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.1021\/acs.jafc.0c01240","article-title":"Synbiotic Effect of Whole Grape Seed Flour and Newly Isolated Kefir Lactic Acid Bacteria on Intestinal Microbiota of Diet-Induced Obese Mice","volume":"68","author":"Seo","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1743-7075-9-105","article-title":"Green tea powder and lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL\/6J mice","volume":"9","author":"Axling","year":"2012","journal-title":"Nutr. Metab."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00394-018-01890-6","article-title":"Diet supplemented with phytochemical epigallocatechin gallate and probiotic lactobacillus fermentum confers second generation synbiotic effects by modulating cellular immune responses and antioxidant capacity in aging mice","volume":"58","author":"Sharma","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zheng, Q., and Chen, Z. (2022). The Nrf2 pathway in liver diseases. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.826204"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jn\/134.3.613","article-title":"Concentrations of proanthocyanidins in common foods and estimations of normal consumption","volume":"134","author":"Gu","year":"2004","journal-title":"J. Nutr."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/1541-4337.12444","article-title":"Rethinking the mechanism of the health benefits of proanthocyanidins: Absorption, metabolism, and interaction with gut microbiota","volume":"18","author":"Tao","year":"2019","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1021\/acs.jafc.1c00430","article-title":"Gut microbiota composition affects procyanidin A2-attenuated atherosclerosis in ApoE\u2013\/\u2013 mice by modulating the bioavailability of its microbial metabolites","volume":"69","author":"Yang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"4750795","DOI":"10.1155\/2019\/4750795","article-title":"Biotransformation of cranberry proanthocyanidins to probiotic metabolites by Lactobacillus rhamnosus enhances their anticancer activity in HepG2 cells in vitro","volume":"2019","author":"Rupasinghe","year":"2019","journal-title":"Oxidative Med. Cell Longev."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"\u00d6zcan, E., Rozycki, M.R., and Sela, D.A. (2021). Cranberry proanthocyanidins and dietary oligosaccharides synergistically modulate Lactobacillus plantarum physiology. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030656"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fct.2016.11.021","article-title":"Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects","volume":"108","author":"Sano","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Zhong, H., Xue, Y., Lu, X., Shao, Q., Cao, Y., Wu, Z., and Chen, G. (2018). The effects of different degrees of procyanidin polymerization on the nutrient absorption and digestive enzyme activity in mice. Molecules, 23.","DOI":"10.3390\/molecules23112916"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/S0007114519003295","article-title":"Condensed tannins decreased the growth performance and impaired intestinal immune function in on-growing grass carp (Ctenopharyngodon idella)","volume":"123","author":"Li","year":"2020","journal-title":"Br. J. Nutr."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1017\/S1357729800052735","article-title":"The effects of graded levels of dietary tannin on the epithelial tissue of the gastro-intestinal tract and liver and kidney masses of boer goats","volume":"74","author":"Mbatha","year":"2002","journal-title":"Anim. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Krawczyk, B., Wityk, P., Ga\u0142\u0119cka, M., and Michalik, M. (2021). The many faces of Enterococcus spp.\u2014Commensal, probiotic and opportunistic pathogen. Microorganisms, 9.","DOI":"10.3390\/microorganisms9091900"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Rossi, F., Amadoro, C., and Colavita, G. (2019). Members of the Lactobacillus genus complex (LGC) as opportunistic pathogens: A review. Microorganisms, 7.","DOI":"10.3390\/microorganisms7050126"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/709\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:54:27Z","timestamp":1760104467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/3\/709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,3]]},"references-count":204,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["molecules29030709"],"URL":"https:\/\/doi.org\/10.3390\/molecules29030709","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,3]]}}}